Washington University School of Medicine-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Washington University School of Medicine - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014268
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Washington University School of Medicine (WUSTL), a subsidiary of University of Washington is a medical university that offers patient care, research, education services and neurology clinical trials. The university provides patient care services such as clinical, find a doctor, referring physicians and others. Its research program comprise post doctoral research opportunities, research labs, knight ADRC, hope center, MS center, infantile spasms, regional, synaptic, and others. The university conducts neurology clinical trials such as headaches, multiple sclerosis and stroke, brain, spinal cord and nervous system, behavior and performance unit, aging, and sleep disorders, among others. It operates through four campus located in St. Louis, the US. Washington University is headquartered in St. Louis, Missouri, the US.

Washington University School of Medicine – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Washington University School of Medicine, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Washington University School of Medicine, Medical Devices Deals, 2011 to YTD 2017 10
Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Washington University School of Medicine, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
C2N Diagnostics Expands Licensing Agreement with Washington University School of Medicine 12
Cerveau Technologies Enters into Agreement with Washington University School of Medicine 13
LEO Pharma Enters into Agreement with Washington University School of Medicine 14
Licensing Agreements 15
Denali Therapeutics Enters into Licensing Agreement with Washington University School of Medicine 15
Washington University School of Medicine – Key Competitors 16
Washington University School of Medicine – Key Employees 17
Washington University School of Medicine – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Government and Public Interest 19
Nov 06, 2017: $6 million supports leukemia research 19
Nov 02, 2017: In autism, too many brain connections may be at root of condition 21
Oct 18, 2017: New gene-altering treatment offered for certain blood cancers 23
Sep 05, 2017: Zika virus shrinks brain tumours in lab tests 25
Sep 05, 2017: Zika virus selectively infects and kills glioblastoma cells in mice 26
Jul 13, 2017: Experimental Zika Virus Vaccines Restrict In Utero Virus Transmission in Mice 27
Jun 14, 2017: UTI treatment reduces E. coli, may offer alternative to antibiotics 28
Jun 07, 2017: Nation’s Largest Suicide Prevention Organization Awards $1Million Research Grant to Researcher in St. Louis 30
Apr 27, 2017: Scientists at Shriners Hospitals for Children re-wire cells to produce arthritis vaccine 31
Apr 19, 2017: Antibody helps detect protein implicated in Alzheimer’s, other diseases 32
Dec 19, 2016: Landmark Alzheimer’s prevention trial to evaluate third drug 34
Oct 26, 2016: Study Questions Benefits of Long-Term Home Oxygen Therapy for COPD Patients with Moderately Low Blood Oxygen Levels 36
Oct 18, 2016: Gates Foundation Awards $1.1 Million Grant for MediBeacon Collaboration with Washington University 38
Sep 23, 2016: Researchers Take a New Step Towards Non-Antibiotic Bladder Infection Therapies 39
Sep 21, 2016: New immunotherapy for leukemia shows promise in small clinical trial 41
Jul 19, 2016: Potential new target identified for treating itch 43
Jul 04, 2016: Immune-based therapy in mice shows promise against pancreatic cancer 44
May 10, 2016: Stem cells from diabetic patients coaxed to become insulin-secreting cells 45
Feb 11, 2016: Venter Institute, International Team of Researchers Publish Paper Outlining Key Genes in Toxoplasma gondii Strains that Contribute to Virulence 46
Feb 03, 2016: Receptors inside nerve cells may be a key to controlling pain 47
Product News 48
Jul 05, 2016: Potential drug target identified for deadly brain cancer 48
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50

List of Tables
Washington University School of Medicine, Pharmaceuticals & Healthcare, Key Facts 2
Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Washington University School of Medicine, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Washington University School of Medicine, Deals By Therapy Area, 2011 to YTD 2017 9
Washington University School of Medicine, Medical Devices Deals, 2011 to YTD 2017 10
Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
C2N Diagnostics Expands Licensing Agreement with Washington University School of Medicine 12
Cerveau Technologies Enters into Agreement with Washington University School of Medicine 13
LEO Pharma Enters into Agreement with Washington University School of Medicine 14
Denali Therapeutics Enters into Licensing Agreement with Washington University School of Medicine 15
Washington University School of Medicine, Key Competitors 16
Washington University School of Medicine, Key Employees 17
Washington University School of Medicine, Subsidiaries 18

★海外企業調査レポート[Washington University School of Medicine-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • H.C. Starck GmbH:企業の戦略的SWOT分析
    H.C. Starck GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Corium International Inc (CORI):製薬・医療:M&Aディール及び事業提携情報
    Summary Corium International Inc (Corium) is a commercial-stage biopharmaceutical company that produces and develops central nervous system pharmaceutical products. The company develops transdermal healthcare products with the help of Corplex technology platform using small molecules. Its products i …
  • Aegean Airlines S.A.:企業の戦略・SWOT・財務情報
    Aegean Airlines S.A. - Strategy, SWOT and Corporate Finance Report Summary Aegean Airlines S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • NLC India Ltd:発電所・企業SWOT分析
    NLC India Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exec …
  • Laing O’Rourke Plc:企業の戦略的SWOT分析
    Laing O'Rourke Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Cellmid Ltd (CDY)-製薬・医療分野:企業M&A・提携分析
    Summary Cellmid Ltd (Cellmid), formerly Medical Therapies Ltd is a developer of therapies and diagnostic tests. The company holds comprehensive portfolio of intellectual property relating to the novel targets midkine and FGF5. It offers products such as midkine ELISA kit, advangen international hair …
  • Samyang Holdings Corp (000070):企業の財務・戦略的SWOT分析
    Summary Samyang Holdings Corp (Samyang) is a holding company engaged in the development and manufacture of food, pharmaceutical and chemical products. The company produces chemicals such as terephthalic acid, engineering plastics, organic chemicals, resins and other specialty chemicals; food materia …
  • Shoprite Holdings Ltd:企業の戦略・SWOT・財務情報
    Shoprite Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Shoprite Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Constellium NV:企業の戦略・SWOT・財務分析
    Constellium NV - Strategy, SWOT and Corporate Finance Report Summary Constellium NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Hargreaves Services Plc:企業の戦略・SWOT・財務情報
    Hargreaves Services Plc - Strategy, SWOT and Corporate Finance Report Summary Hargreaves Services Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • The Lubrizol Corp:企業の戦略的SWOT分析
    The Lubrizol Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • BioHorizons Inc-医療機器分野:企業M&A・提携分析
    Summary BioHorizons Inc (BioHorizons), a subsidiary of Henry Schein Inc is a medical device company that manufactures and develops dental products. The company’s products include dental implants, short implants, guided surgery kits, and others. It provides overdentures, gum grafting and bone graftin …
  • The Juroku Bank Ltd:企業の戦略・SWOT・財務情報
    The Juroku Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary The Juroku Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Southern Co:企業の発電所・SWOT分析2018
    Southern Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (execut …
  • Ambu AS (AMBU B):医療機器:M&Aディール及び事業提携情報
    Summary Ambu A/S (Ambu) is a medical device company that manufactures and markets life supporting devices. It focuses on single-use devices for anesthesia, patient monitoring and diagnostics, and emergency care. It serves hospitals, clinics, sleep laboratories and rescue services. The major products …
  • Baron Oil Plc (BOIL):石油・ガス:M&Aディール及び事業提携情報
    Summary Baron Oil Plc (Baron Oil), formerly Gold Oil PLC is an oil and gas exploration and production company. The company identifies and develops crude oil and natural gas interests in Latin America including Peru and Colombia. It holds working interests of Nancy Burdine Maxine oil field, oil and g …
  • Shanghai SECCO Petrochemical Co Ltd:企業の戦略的SWOT分析
    Shanghai SECCO Petrochemical Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Huron Consulting Group Inc:企業のM&A・事業提携・投資動向
    Huron Consulting Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Huron Consulting Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Isrotel Hotels Management Inc.
    Isrotel Hotels Management Inc. - Strategy, SWOT and Corporate Finance Report Summary Isrotel Hotels Management Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Atara Biotherapeutics Inc (ATRA):企業の財務・戦略的SWOT分析
    Atara Biotherapeutics Inc (ATRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆